Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

1.6K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antioxidant Ascorbic Acid Influences Cell-mediated Alterations in Localized Hydrogel Crosslinking and Affects Neo-Cartilage Connectivity in Hydrolytically Degradable Hydrogels.

Macromolecular bioscience·2026
Same author

An injectable biomimetic hydrogel with tethered TGF<i>β</i>3 for treatment in a rat growth plate injury model.

Biomedical materials (Bristol, England)·2026
Same author

The foreign body response to biomaterial implants is reduced by co-inhibition of TLR2 and TLR4.

Acta biomaterialia·2025
Same author

Damage Associated Molecular Patterns (DAMPs) Mediate the Foreign Body Response to Poly(ethylene glycol) Diacrylate Hydrogels via Toll like Receptors.

ACS biomaterials science & engineering·2025
Same author

Controlled Mechanical Property Gradients Within a Digital Light Processing Printed Hydrogel-Composite Osteochondral Scaffold.

Annals of biomedical engineering·2024
Same author

Cell- and Serum-Derived Proteins Act as DAMPs to Activate RAW 264.7 Macrophage-like Cells on Silicone Implants.

ACS biomaterials science & engineering·2024

Related Experiment Video

Updated: May 4, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

5.3K

Tissue engineering approaches to cell-based type 1 diabetes therapy.

Luke D Amer1, Melissa J Mahoney, Stephanie J Bryant

  • 11 Department of Chemical and Biological Engineering, University of Colorado , Boulder, Colorado.

Tissue Engineering. Part B, Reviews
|January 15, 2014
PubMed
Summary

Tissue engineering using 3D constructs with extracellular matrix (ECM) molecules shows promise for enhancing cell-based therapies for type 1 diabetes. This approach improves beta-cell viability and insulin secretion, offering a potential breakthrough for diabetes treatment.

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

9.6K

Related Experiment Videos

Last Updated: May 4, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

5.3K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

9.6K

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Endocrinology

Background:

  • Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the destruction of insulin-producing pancreatic beta-cells.
  • Current cell-based therapies for T1DM, involving beta-cell transplantation, face limitations in long-term efficacy.
  • The need for improved strategies to restore insulin production and glycemic control in diabetic patients is critical.

Purpose of the Study:

  • To review advancements in tissue engineering for enhancing cell-based therapies for type 1 diabetes.
  • To explore the potential of three-dimensional (3D) culture systems incorporating extracellular matrix (ECM) molecules.
  • To discuss cell sources, essential ECM components, and 3D culture techniques for improving beta-cell function.

Main Methods:

  • Review of existing literature on cell sources for beta-cell replacement.
  • Analysis of the role of specific extracellular matrix (ECM) molecules in supporting beta-cell survival and function.
  • Examination of various three-dimensional (3D) culture techniques applied to insulin-producing cells.

Main Results:

  • Culturing insulin-producing cells in 3D environments generally enhances cell viability and insulin secretion compared to 2D cultures.
  • Incorporation of specific ECM molecules into 3D constructs can further improve beta-cell function and survival.
  • Different cell sources and ECM compositions yield varying effects on therapeutic efficacy.

Conclusions:

  • Tissue engineering approaches, particularly 3D cultures with ECM, offer significant potential to improve the efficacy of cell-based therapies for type 1 diabetes.
  • Optimizing cell sources, ECM composition, and 3D culture methods is key to advancing these therapies.
  • This strategy holds promise for more effective and potentially long-term management of diabetes.